{"id": "chatcmpl-8JYPpV0VH0LzbC675IanoY8mrPhvC", "object": "chat.completion", "created": 1699671217, "model": "gpt-4-0613", "choices": [{"index": 0, "message": {"role": "assistant", "content": "1. The trial was randomised.\n2. The trial was a phase II trial.\n3. The patients involved in the trial had inoperable LAPC.\n4. The patients were offered gemcitabine and capecitabine.\n5. The treatment with gemcitabine and capecitabine was for 16 weeks.\n6. The combination of gemcitabine and capecitabine is referred to as GEM-CAP."}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 68, "completion_tokens": 95, "total_tokens": 163}, "temperature": 0, "max_tokens": 512, "top_p": 1, "frequency_penalty": 0, "presence_penalty": 0, "messages": [{"role": "system", "content": "Statement: This was a randomised phase II trial in which patients with inoperable LAPC were offered gemcitabine and capecitabine (GEM-CAP) for 16 weeks.\n\nList all the facts we explicitly know from the statement. Make each fact as atomic as possible."}]}